EMA — authorised 18 May 2011
- Local brand name: Eliquis
- Status: approved
EMA authorised Eliquis on 18 May 2011
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 18 May 2011; EMA has authorised it.
Bristol-Myers Squibb is the originator. The local marketing authorisation holder may differ — check the official source linked above.